Categories: India

BRIEF-Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 – SEC Filing

Sept 21 (Reuters) – Recursion Pharmaceuticals, Inc. : * RECURSION PHARMACEUTICALS – ENTERS AMENDMENT TO MASTER AGREEMENT WITH TEMPUS ON SEPT 15, 2026 – SEC FILING * RECURSION PHARMACEUTICALS – EXTENDS

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

OpenAI secures $11 billion funding at $1.25 trillion valuation, Bloomberg News reports

By Krystal Hu Nov 6 (Reuters) - OpenAI has closed on new funding of $11…

1 second ago

No Robbie Avila, but Saint Louis holds off Missouri

Amari McCottry and Ishan Sharma scored 17 points apiece to lead Saint Louis to a…

5 minutes ago

Ace Buckner leads Clemson to narrow victory over American

Ace Buckner scored 26 points on 9-for-14 shooting, and host Clemson held on for an…

9 minutes ago

OpenAI secures $11 billion funding at $1.25 trillion valuation, Bloomberg News reports

By Krystal Hu Nov 6 (Reuters) - OpenAI has closed on new funding of $11…

11 minutes ago

Google executive Donald Harrison resigns from SpaceX board

Nov 6 (Reuters) - SpaceX disclosed on Friday that Google executive Donald Harrison has resigned…

12 minutes ago

NBA Standings

Nov 7 (Stats Perform) - Standings from the NBA games on Saturday Eastern Conference Atlantic…

16 minutes ago